CD163 and breast carcinoma: Overall, at least two molecular mechanism for tumor-supporting function of CD163+ TAMs were identified to date: inhibition of tumor suppressor TAp73 in breast cancer and activation of STAT3 signaling in TAMs and in r fibrosarcoma cells (58, 63, 64).